Clinical trial
An Exploratory Study of EBV mRNA Vaccine for the Prevention of EBV-Related Diseases After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07674199 is registered in ClinicalTrials.gov with The General Hospital of Western Theater Command as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Study of EBV mRNA Vaccine for the Prevention of EBV-Related Diseases After Allogeneic Hematopoietic Stem Cell Transplantation
- Lead sponsor
- The General Hospital of Western Theater Command
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- June 18, 2026
- Completion date
- December 31, 2031
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
patients after hematopoietic stem cell transplantation